214 related articles for article (PubMed ID: 12894505)
21. The differential susceptibility of A427 and A549 cell lines to the growth-inhibitory effects of ET-18-OCH3 does not correlate with the relative effects of the alkyl-lysophospholipid on the incorporation of fatty acids into cellular phospholipids.
Lu X; Arthur G
Cancer Res; 1992 May; 52(10):2813-7. PubMed ID: 1581895
[TBL] [Abstract][Full Text] [Related]
22. Activation of the RAF/mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway mediates apoptosis induced by chelerythrine in osteosarcoma.
Yang R; Piperdi S; Gorlick R
Clin Cancer Res; 2008 Oct; 14(20):6396-404. PubMed ID: 18927278
[TBL] [Abstract][Full Text] [Related]
23. Flagellin and lipopolysaccharide stimulate the MEK-ERK signaling pathway in chicken heterophils through differential activation of the small GTPases, Ras and Rap1.
Kogut MH; Genovese KJ; He H
Mol Immunol; 2007 Mar; 44(7):1729-36. PubMed ID: 17045653
[TBL] [Abstract][Full Text] [Related]
24. Ras-mediated intestinal epithelial cell transformation requires cyclooxygenase-2-induced prostaglandin E2 signaling.
Repasky GA; Zhou Y; Morita S; Der CJ
Mol Carcinog; 2007 Dec; 46(12):958-70. PubMed ID: 17477350
[TBL] [Abstract][Full Text] [Related]
25. Different mechanisms of inhibition by alkyl-lysophospholipid and phorbol ester of granulocyte-macrophage colony-stimulating factor binding to human leukemic cell lines.
Shoji M; Fukuhara T; Winton EF; Berdel WE; Vogler WR
Exp Hematol; 1994 Jan; 22(1):13-8. PubMed ID: 8282054
[TBL] [Abstract][Full Text] [Related]
26. Transmembrane signaling pathway mediates oxidized low-density lipoprotein-induced expression of plasminogen activator inhibitor-1 in vascular endothelial cells.
Sangle GV; Zhao R; Shen GX
Am J Physiol Endocrinol Metab; 2008 Nov; 295(5):E1243-54. PubMed ID: 18796547
[TBL] [Abstract][Full Text] [Related]
27. Functional interactions of Raf and MEK with Jun-N-terminal kinase (JNK) result in a positive feedback loop on the oncogenic Ras signaling pathway.
Adler V; Qu Y; Smith SJ; Izotova L; Pestka S; Kung HF; Lin M; Friedman FK; Chie L; Chung D; Boutjdir M; Pincus MR
Biochemistry; 2005 Aug; 44(32):10784-95. PubMed ID: 16086581
[TBL] [Abstract][Full Text] [Related]
28. Site-specific phosphorylation of raf in cells containing oncogenic ras-p21 is likely mediated by jun-N-terminal kinase.
Adler V; Bowne W; Michl J; Sookraj KA; Ikram K; Pestka S; Izotova L; Zenilman M; Friedman FK; Qu Y; Pincus MR
Ann Clin Lab Sci; 2008; 38(1):47-56. PubMed ID: 18316782
[TBL] [Abstract][Full Text] [Related]
29. Farnesylthiosalicylic acid induces caspase activation and apoptosis in glioblastoma cells.
Amos S; Redpath GT; Polar G; McPheson R; Schiff D; Hussaini IM
Cell Death Differ; 2006 Apr; 13(4):642-51. PubMed ID: 16239932
[TBL] [Abstract][Full Text] [Related]
30. Perturbations of cellular acylation processes by the synthetic alkyl-lysophospholipid 1-O-octadecyl-2-O-methylglycero-3-phosphocholine do not correlate with inhibition of proliferation of MCF7 and T84 cell lines.
Lu X; Arthur G
Cancer Res; 1992 May; 52(10):2806-12. PubMed ID: 1581894
[TBL] [Abstract][Full Text] [Related]
31. Functional Rac-1 and Nck signaling networks are required for FGF-2-induced DNA synthesis in MCF-7 cells.
Liu JF; Chevet E; Kebache S; Lemaitre G; Barritault D; Larose L; Crépin M
Oncogene; 1999 Nov; 18(47):6425-33. PubMed ID: 10597244
[TBL] [Abstract][Full Text] [Related]
32. Ras effector pathways modulate scatter factor-stimulated NF-kappaB signaling and protection against DNA damage.
Fan S; Meng Q; Laterra JJ; Rosen EM
Oncogene; 2007 Jul; 26(33):4774-96. PubMed ID: 17297451
[TBL] [Abstract][Full Text] [Related]
33. Cytokinetic and morphologic differences in ovarian cancer cells treated with ET-18-OCH3 and the DNA-interacting agent, etoposide.
Fujiwara K; Koike H; Ohishi Y; Shirafuji H; Kohno I; Modest EJ; Kataoka S
Anticancer Res; 1997; 17(3C):2159-67. PubMed ID: 9216681
[TBL] [Abstract][Full Text] [Related]
34. Sulindac-derived Ras pathway inhibitors target the Ras-Raf interaction and downstream effectors in the Ras pathway.
Waldmann H; Karaguni IM; Carpintero M; Gourzoulidou E; Herrmann C; Brockmann C; Oschkinat H; Müller O
Angew Chem Int Ed Engl; 2004 Jan; 43(4):454-8. PubMed ID: 14735533
[No Abstract] [Full Text] [Related]
35. Rhein lysinate suppresses the growth of breast cancer cells and potentiates the inhibitory effect of Taxol in athymic mice.
Lin YJ; Zhen YS
Anticancer Drugs; 2009 Jan; 20(1):65-72. PubMed ID: 19343002
[TBL] [Abstract][Full Text] [Related]
36. Control of PDGF-induced reactive oxygen species (ROS) generation and signal transduction in human lens epithelial cells.
Chen KC; Zhou Y; Zhang W; Lou MF
Mol Vis; 2007 Mar; 13():374-87. PubMed ID: 17392688
[TBL] [Abstract][Full Text] [Related]
37. Annexin A6 stimulates the membrane recruitment of p120GAP to modulate Ras and Raf-1 activity.
Grewal T; Evans R; Rentero C; Tebar F; Cubells L; de Diego I; Kirchhoff MF; Hughes WE; Heeren J; Rye KA; Rinninger F; Daly RJ; Pol A; Enrich C
Oncogene; 2005 Sep; 24(38):5809-20. PubMed ID: 15940262
[TBL] [Abstract][Full Text] [Related]
38. Glycosylated antitumor ether lipids are more effective against oncogene-transformed fibroblasts than alkyllysophospholipids.
Samadder P; Byun HS; Bittman R; Arthur G
Anticancer Res; 1998; 18(1A):465-70. PubMed ID: 9568121
[TBL] [Abstract][Full Text] [Related]
39. Removal of breast cancer cells from bone marrow by in vitro purging with ether lipids and cryopreservation.
Dietzfelbinger HF; Kühn D; Zafferani M; Hanauske AR; Rastetter JW; Berdel WE
Cancer Res; 1993 Aug; 53(16):3747-51. PubMed ID: 8339286
[TBL] [Abstract][Full Text] [Related]
40. Raf and RhoA cooperate to transform intestinal epithelial cells and induce growth resistance to transforming growth factor beta.
Du J; Jiang B; Coffey RJ; Barnard J
Mol Cancer Res; 2004 Apr; 2(4):233-41. PubMed ID: 15140945
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
